Akalazya Hastalarında Anestezi Yönetimi
Özet
Akalazya, alt özofagus sfinkterinin gevşememesi ve yemek borusunda peristaltizm kaybı ile karakterize nadir bir motilite bozukluğudur. Bu durum, özellikle anestezi indüksiyonu sırasında ciddi bir pulmoner aspirasyon riski oluşturur; çünkü sindirilmemiş gıdalar ve sıvılar özofagusta birikebilir. Tanı konulmamış vakalarda, hastalar semptomlarını yapısal bir sorun olarak kanıksadığı için anestezi ekibi hazırlıksız yakalanabilir. Preoperatif dönemde ayrıntılı disfaji ve regürjitasyon öyküsü alınması, akciğer grafisi ve BT incelemelerinde özofageal dilatasyon bulgularının kontrol edilmesi hayati önem taşır. Aspirasyon riskini minimize etmek için operasyon öncesi 24-48 saatlik sıvı diyeti ve en az 8-24 saatlik tam açlık uygulanmalıdır. Anestezi yönetiminde hızlı seri indüksiyon (HSİ) ve endotrakeal entübasyon standart yaklaşımdır. Tedavide son yıllarda popülerleşen Per-oral Endoskopik Miyotomi (POEM) sırasında ise karbondioksit insüflasyonuna bağlı gelişebilecek hiperkapni, pnömoperitonyum ve pnömotoraks gibi komplikasyonlar yakından takip edilmelidir. Sonuç olarak, akalazya hastalarında dikkatli bir preoperatif değerlendirme ve titiz anestezi yönetimi, hayatı tehdit eden solunumsal komplikasyonların önlenmesinde temel faktördür.
Achalasia is a rare motility disorder characterized by the failure of the lower esophageal sphincter to relax and the absence of peristalsis in the esophagus. This condition poses a significant risk of pulmonary aspiration, particularly during anesthesia induction, as undigested food and liquids can accumulate in the esophagus. In undiagnosed cases, patients may perceive their symptoms as a structural issue, potentially leaving the anesthesia team unprepared for unexpected aspiration. In the preoperative period, taking a detailed history of dysphagia and regurgitation, and checking for esophageal dilation in chest X-rays and CT scans are of vital importance. To minimize the risk of aspiration, a liquid diet for 24-48 hours and complete fasting for at least 8-24 hours prior to surgery should be implemented. Rapid sequence induction (RSI) and endotracheal intubation are the standard approaches in anesthesia management. During Per-oral Endoscopic Myotomy (POEM), which has gained popularity in treatment recently, complications such as hypercapnia, pneumoperitoneum, and pneumothorax due to carbon dioxide insufflation must be closely monitored. In conclusion, careful preoperative evaluation and meticulous anesthesia management in achalasia patients are the primary factors in preventing life-threatening respiratory complications.
Referanslar
Abir F, Modlin I, Kidd M, Bell R. Surgical treatment of achalasia: Current status and controversies. Dig Surg 2004;21:165-76.
Boeckxstaens GE, Zaninotto G, Richter JE. Akalazya. Lancet. 2014; 383:83-93.
HR Gockel, J Schumacher, I Gockel, et al. Achalasia: will genetic studies provide insights? Hum Genet 2010;128: 353-64.
Allgrove J, Clayden GS, Grant DB, Macaulay JC. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1978; 1:1284.
Verma S, Brown S, Dakkak M, Bennett JR. Association of adult achalasia and alacrima. Dig Dis Sci 1999; 44:876.
Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil 2010; 22:256.
A Farrukh, J DeCaestecker, JF Mayberry An epidemiological study of achalasia among the south Asian population of Leicester, 1986–2005 Dysphagia, 2008(23); 161-4
S Birgisson, JE Richter Achalasia in Iceland, 1952–2002: an epidemiologic study Dig Dis Sci, 2007(52);1855-60.
N Gennaro, G Portale, C Gallo, et al. Esophageal achalasia in the Veneto region: epidemiology and treatment. Epidemiology and treatment of achalasia J Gastrointest Surg, 2011(15); 423-8.
BK Enestvedt, JL Williams, A Sonnenberg Epidemiology and practice patterns of achalasia in a large multi-centre database Aliment Pharmacol Ther, 2011(13);1209-14.
de Oliveira RB, Rezende Filho J, Dantas RO, Iazigi N. The spectrum of esophageal motor disorders in Chagas' disease. Am J Gastroenterol 1995; 90:1119.
Booy JD, Takata J, Tomlinson G, Urbach DR. The prevalence of autoimmune disease in patients with esophageal achalasia. Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus. 2012;25(3):209-13.
Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol 1994; 18:327.
Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996; 111:648.
Sodikoff JB, Lo AA, Shetuni BB, Kahrilas PJ, Yang GY, Pandolfino JEJN, et al. Histopathologic patterns among achalasia subtypes. 2016;28(1):139- 45.
Mearin F, Papo M, Malagelada JR. Impaired gastric relaxation in patients with achalasia. Gut 1995; 36:363.
Eckardt VF, Stauf B, Bernhard G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterology 1999; 116:1300.
Fisichella PM, Raz D, Palazzo F, et al. Clinical, radiological, and manometric profile in 145 patients with untreated achalasia. World J Surg 2008; 32:1974.
Howard PJ, Maher L, Pryde A, et al. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 1992; 33:1011.
Hulselmans M, Vanuytsel T, Degreef T, Sifrim D, Coosemans W, Lerut T,et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2010;8(1):30-5.
Vantrappen G, Hellemans J, Deloof W, Valembois P, Vandenbroucke J.Treatment of achalasia with pneumatic dilatations. Gut. 1971;12(4):268-75.
Seeman H, Traube M. Hiccups and achalasia. Ann Intern Med 1991; 115:711.
Japan Esophageal Society Descriptive rules for achalasia of the esophagus. 2012: 4th edition. Esophagus. 2017;14:275–89.
Eckardt VF. Clinical presentations and complications of achalasia. Gastrointestinal endoscopy clinics of North America. 2001;11(2):281-92.
Eckardt VF, Köhne U, Junginger T, Westermeier T. Risk factors for diagnostic delay in achalasia. Digestive diseases and sciences. 1997;42(3):580-5.
Sandler RS, Bozymski EM, Orlando RC. Failure of clinical criteria to distinguish between primary achalasia and achalasia secondary to tumor. Digestive diseases and sciences. 1982;27(3):209-13.
Scherer JR, Kwiatek MA, Soper NJ, Pandolfino JE, Kahrilas PJ. Functional esophagogastric junction obstruction with intact peristalsis: a heterogeneous syndrome sometimes akin to achalasia. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2009;13(12):2219-25.
Kessing BF, Bredenoord AJ, Smout AJ. Erroneous diagnosis of gastroesophageal reflux disease in achalasia. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2011;9(12):1020-4.
Cole TJ, Turner MA. Göğüs radyografilerinde gastrointestinal hastalık belirtileri. Radyografik. 1993;13:1013-34.
Vaezi MF, Richter JE. Current therapies for achalasia: comparison and efficacy. Journal of clinical gastroenterology. 1998;27(1):21-35.
Rohof WO, Lei A, Boeckxstaens GE. Esophageal stasis on a timed barium esophagogram predicts recurrent symptoms in patients with long-standing achalasia. Am J Gastroenterol 2013; 108:49.
Neyaz Z, Gupta M, Ghoshal UC. How to perform and interpret timed barium esophagogram. J Neurogastroenterol Motil 2013; 19:251.
Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG Clinical Guidelines: Diagnosis and Management of Achalasia. The American journal of gastroenterology. 2020;115(9):1393-411.
Miller LS, Liu JB, Barbarevech CA, et al. High-resolution endoluminal sonography in achalasia. Gastrointest Endosc 1995; 42:545.
Pandolfino JE, Ghosh SK, Rice J, et al. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol 2008; 103:27.
Kahrilas PJ, Ghosh SK, Pandolfino JE. Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol 2008; 42:627.
Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society. 2015;27(2):160-74.
Schlottmann F, Herbella FA, Patti MG. Understanding the Chicago Classification: From Tracings to Patients. Journal of neurogastroenterology and motility. 2017;23(4):487-94.
Eckardt VF, Hoischen T, Bernhard G. Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation. Eur J Gastroenterol Hepatol 2008; 20:956.
Vela MF, Richter JE, Wachsberger D, et al. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. Am J Gastroenterol 2004; 99:1029.
Sandler RS, Nyrén O, Ekbom A, et al. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA 1995; 274:1359.
Csendes A, Braghetto I, Burdiles P, et al. Very late results of esophagomyotomy for patients with achalasia: clinical, endoscopic, histologic, manometric, and acid reflux studies in 67 patients for a mean follow-up of 190 months. Ann Surg 2006; 243:196.
Streitz JM Jr, Ellis FH Jr, Gibb SP, Heatley GM. Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients. Ann Thorac Surg 1995; 59:1604.
Leeuwenburgh I, Scholten P, Alderliesten J, et al. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol 2010; 105:2144.
Zendehdel K, Nyrén O, Edberg A, Ye W. Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am J Gastroenterol 2011; 106:57.
Zaninotto G, Rizzetto C, Zambon P, et al. Long-term outcome and risk of oesophageal cancer after surgery for achalasia. Br J Surg 2008; 95:1488.
Annese V, Bassotti G, Coccia G, Dinelli M, D’Onofrio V, Gatto G, et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut. 2000;46(5):597-600.
Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. The New England journal of medicine. 1995;332(12):774-8.
Inoue, H. Minami, H. Kobayashi, Y. Şato, Y. Kaga, M. Suzuki, M. Satodate, H. Odaka, N. Itoh, "Peroral endoscopic myotomy (POEM) for esophageal achalasia". Endoscopy 2010(4): 265-71.
Tuason, Joshua; Inoue, Haruhiro" Current status of achalasia management: a review on diagnosis and treatment". Journal of Gastroenterology 2017(4): 401–6.
Heller E, Chir MGM. Extramukose kerkioplastic beim chronischen Kardiospasmus mit Dilation des Oesophagus. 1914.
Shiino Y, Awad ZT, Haynatzki GR, Davis RE, Hinder RA, Filipi CJ. Postmyotomy dysphagia after laparoscopic surgery for achalasia. World J Gastroenterol 2003;9:1129-31.
Esposito C, Mendoza-Sagaon M, Roblot-Maigret B, Amici G,Desruelle P,Montupet P. Complications of laparoscopic treatment of esophageal achalasia in children. J Pediatr Surg 2000;35:680-3.
Inadomi C, Yamashita K, Takada M, Terao Y, Fukusaki M. Regurgitation during anesthesia induction in a patient with preoperatively undiagnosed esophageal achalasia. J Jpn Soc Clin Anesth. 2005;25:347–51.
Layton J, Ward PW, Miller DW, Roan RM. Acute respiratory failure secondary to esophageal dilation from undiagnosed achalasia. A A Case Rep. 2014;3:65–7.
Kendall AP, Lin E. Respiratory failure as presentation of esophageal achalasia. Anesthesia.. 1991; 46:1039-40
Löser B, Werner YB, Punke MA, et al. Anesthetic considerations for patients with esophageal achalasia undergoing peroral endoscopic myotomy: a retrospective case series review. Can J Anaesth. 2017;64:480–8.
Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American society of anesthesiologists task force on preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. Anesthesiology. 2017;126:376–93.
Inoue H, Shiwaku H, Iwakiri K, et al. Clinical practice guidelines for peroral endoscopic myotomy. Dig Endosc. 2018;30:563–79.
Tanaka E, Murata H, Minami H, Sumikawa K. Anesthetic management of peroral endoscopic myotomy for esophageal achalasia: a retrospective case series. J Anesth. 2014;28:456–9.
Nishihara Y, Yoshida T, Ooi M, Obata N, Izuta S, Mizobuchi S. Anesthetic management and associated complications of peroral endoscopic myotomy: a case series. World J Gastrointest Endosc. 2018;10:193–9.
Yang D, Pannu D, Zhang Q, White JD, Draganov PV. Evaluation of anesthesia management, feasibility and efficacy of peroral endoscopic myotomy (POEM) for achalasia performed in the endoscopy unit. Endosc Int Open. 2015;3:289–95.
Darisetty S, Nabi Z, Ramchandani M, Chavan R, Kotla R, Nageshwar Reddy D. Anesthesia in per-oral endoscopic myotomy: a large tertiary care centre experience. Indian J Gastroenterol. 2017;36:305–12.
Jayan N, Jacob JS, Mathew M, Mukkada RJ. Anesthesia for peroral endoscopic myotomy: a retrospective case series. J Anaesthesiol Clin Pharmacol. 2016;32:379–81.
Inoue H, Tianle KM, Ikeda H, et al. Peroral endoscopic myotomy for esophageal achalasia: technique, indication, and outcomes. Thorac Surg Clin. 2011;21:519–25
Friedrich K, Scholl SG, Beck S, et al. bng-Study-Group. Respiratory complications in outpatient endoscopy with endoscopist-directed sedation. J Gastrointestin Liver Dis. 2014;23:255–9.
Goudra B, Singh PM, Gouda G, Sinha AC. Peroral endoscopic myotomy-initial experience with anesthetic management of 24 procedures and systematic review. Anesth Essays Res. 2016;10:297–300.
Saxena P, Pippenger R, Khashab MA. Preventing aspiration during peroral endoscopic myotomy. J Anesth. 2014;28:959.
Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA. 2015;313:1841–52.
Schlottmann F, Luckett DJ, Fine J, Shaheen NJ, Patti MG. Laparoscopic Heller myotomy versus Peroral Endoscopic Myotomy (POEM) for achalasia: a systematic review and meta-analysis. Ann Surg. 2018;267:451–60.
Andreoll NA, Lope LR, Malafai O. Heller’s myotomy: a hundred years of success! Arq Bras Cir Dig. 2014;27:1–2.
Birenbaum A, Hajage D, Roche S, et al. IRIS Investigators Group. Effect of cricoid pressure compared with a sham procedure in the rapid sequence induction of anesthesia: the IRIS randomized clinical trial. JAMA Surg. 2019;154:9–17
Haito-Chavez Y, Inoue H, Beard KW, et al. Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an International Multicenter Study. Am J Gastroenterol. 2017;112:1267–76.
Gelb AW, Morriss WW, Johnson W, Merry AF. International Standards for a Safe Practice of Anesthesia Workgroup. World Health Organization-World Federation of Societies of Anaesthesiologists (WHO-WFSA) international standards for a safe practice of anesthesia. Can J Anaesth. 2018;65:698–708.
Stavropoulos SN, Desilets DJ, Fuchs K-H, et al. Per-oral endoscopic myotomy white paper summary. Gastrointest Endosc. 2014;80:1–15.
Werner YB, von Renteln D, Noder T, et al. Early adverse events of per-oral endoscopic myotomy. Gastrointest Endosc. 2017;85:708–18
von Renteln D, Inoue H, Minami H, Werner YB, Pace A, Kersten JF, et al. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol. 2012;107:411–7.
Swanstrom LL, Rieder E, Dunst CM. A stepwise approach and early clinical experience in peroral endoscopic myotomy for the treatment of achalasia and esophageal motility disorders. J Am Coll Surg 2011;213:751–56.
Ren Z, Zhong Y, Zhou P, Xu M, Cai M, Li L, Shi Q, Yao L. Perioperative management and treatment for complications during and after peroral endoscopic myotomy (POEM) for esophageal achalasia (EA) (data from 119 cases). Surg Endosc 2012;26:3267–72.
Deb S, Deschamps C, Allen MS, Nichols FC III, Cassivi SD, Crownhart BS, Pairolero PC Laparoscopic esophageal myotomy for achalasia: factors affecting functional outcomes. Ann Thorac Surg 2005(80);1191–4 .
Raymond DP, Seder CW, Wright CD, et al. Predictors of major morbidity or mortality after resection for esophageal cancer: a society of thoracic surgeons general thoracic surgery database risk adjustment model. Ann Thorac Surg 2016; 102:207–14.
Sihag S, Kosinski AS, Gaissert HA, et al. Minimally invasive versus open esophagectomy for esophageal cancer: a comparison of early surgical outcomes from the society of thoracic surgeons national database. Ann Thorac Surg 2016; 101:1281–9.
FA Herbella, JL Aquino, S Stefani-Nakano, et al.Treatment of achalasia: lessons learned with Chagas' disease Dis Esophagus 2008(21); 461-7
Boeckxstaens GE, Annese V, des Varannes SB, et al. Laparoscopic Heller myotomy versus pneumatic dilation for idiopathic achalasia. N Engl J Med. 2011; 364:1807–16.
Lynch KL, Pandolfino JE, Howden CW, Kahrilas PJ. Pneumatic dilatation and major complications of Heller myotomy for achalasia: a single-center experience and systematic review of the literature.Ben J Gastroenterol. 2012; 107 (12):1817–25.
Coda S, Antonellis F, Sagkaropulos S, et al. Complete Endoscopic Closure of Large Esophageal Perforation After Pneumatic Dilation in a Patient with Achalasia(kliping). J Laparoendosc Adv Surg Tech A. 2012; 22 (8):815–18.
